The Williams-Beuren Syndrome—A Window into Genetic Variants Leading to the Development of Cardiovascular Disease

1. PoberBR 2010 Williams-Beuren syndrome. N Engl J Med 362 239 252

2. PoberBRJohnsonMUrbanZ 2008 Mechanisms and treatment of cardiovascular disease in Williams-Beuren Syndrome. J Clin Invest 118 1606 1615

3. Del PasquaARinelliGToscanoAIacobelliRDigilioC 2009 New findings concerning cardiovascular manifestations emerging from long-term follow-up of 150 patients with the Williams-Beuren-Beuren Syndrome. Cardiol Young 19 563 567

4. GoergenCJLiHHFranckeUTaylorCA 2011 Induced chromosome deletion in a Williams-Beuren Syndrome mouse model causes cardiovascular sbnormalities. J Vasc Res 48 119 129

5. Del CampoMAntonellAMaganoLFMuñozFJFloresR 2006 Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension. Am J Hum Genet 78 533 542

6. LandmesserUSpiekermannSDikalovSTatgeHWilkeR 2002 Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106 3073 3078

7. CampuzanoVSeguraMTerradoVSánchez-RodríguezCCoustestM 2012 Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren syndrome. PLoS Genet 8 e1002458 doi:10.1371/journal.pgen.1002458

8. DikalovaAEBikineyevaATBudzynKNazarewiczRRMcCannL 2010 Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107 106 116

9. AdamsGNLaRuschGAStavrouEZhouYNiemanMT 2011 Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis. Blood 117 3929 3937

10. Kris-EtheronPMLichtensteinAHHowardBVSteinbergDWiztumJL 2004 Antioxidant vitamin supplements and cardiovascular disease. Circulation 110 637 641

11. SimonsenURodriguez-RodriguezRDalsgaardTBuusNHStankeviciusE 2009 Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilation. Pharmacol Rep 61 105 115

12. HoffmannDSWeydertCJLazartiguesEKutschekeWJKienzleMF 2008 Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia. Hypertension 51 1058 1065

13. HeumüllerSWindSBarbosa-SicardESchmidtHHBusseR 2008 Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51 211 217

14. StefanskaJSokolowskaMSarniakAWlodarczykADoniecZ 2010 Apocynin decreases hydrogen peroxide and nitrate concentrations in exhaled breath in healthy subjects. Pulm Pharmacol Ther 23 48 54

15. TrueALOliveMBoehmMSanHWestrickRJ 2007 Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 101 893 901

16. GlaserCBMorserJClarkeJHBlaskoEMcLeanK 1992 Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. J Clin Invest 90 2565 2573